These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26404412)

  • 1. Identification and in silico prediction of metabolites of the model compound, tebufenozide by human CYP3A4 and CYP2C19.
    Shirotani N; Togawa M; Ikushiro S; Sakaki T; Harada T; Miyagawa H; Matsui M; Nagahori H; Mikata K; Nishioka K; Hirai N; Akamatsu M
    Bioorg Med Chem; 2015 Oct; 23(20):6594-601. PubMed ID: 26404412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and in silico prediction of metabolites of tebufenozide derivatives by major human cytochrome P450 isoforms.
    Edamatsu H; Yagawa M; Ikushiro S; Sakaki T; Nakagawa Y; Miyagawa H; Akamatsu M
    Bioorg Med Chem; 2020 May; 28(9):115429. PubMed ID: 32201191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective Metabolism of Omeprazole by Cytochrome P450 2C19 and 3A4: Mechanistic Insights from DFT Study.
    Jana K; Bandyopadhyay T; Ganguly B
    J Phys Chem B; 2018 Jun; 122(22):5765-5775. PubMed ID: 29741901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of fractions metabolized by hepatic CYP enzymes using a concept of inter-system extrapolation factors (ISEFs) - a comparison with the chemical inhibition method.
    Umehara KI; Huth F; Gu H; Schiller H; Heimbach T; He H
    Drug Metab Pers Ther; 2017 Dec; 32(4):191-200. PubMed ID: 29176011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
    Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches.
    Davis MA; Barnette DA; Flynn NR; Pidugu AS; Swamidass SJ; Boysen G; Miller GP
    Chem Res Toxicol; 2019 Jun; 32(6):1151-1164. PubMed ID: 30925039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Approach to Predict the Impact of Inflammation on the Pharmacokinetics of CYP2C19 and CYP3A4 Substrates.
    Simon F; Gautier-Veyret E; Truffot A; Chenel M; Payen L; Stanke-Labesque F; Tod M
    Pharm Res; 2021 Mar; 38(3):415-428. PubMed ID: 33686560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of capsicine on rat cytochrome P450 isoforms CYP1A2, CYP2C19, and CYP3A4.
    Zhu HD; Gu N; Wang M; Kong HR; Zhou MT
    Drug Dev Ind Pharm; 2015; 41(11):1824-8. PubMed ID: 25678312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Docking Supplements an In vitro Determination of the Leading CYP Isoform for Arylpiperazine Derivatives.
    Ulenberg S; Bączek T; Zieliñska J; Belka M; Król M; Herold F
    Comb Chem High Throughput Screen; 2019; 22(6):370-378. PubMed ID: 31284855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.
    Karaca RO; Kalkisim S; Altinbas A; Kilincalp S; Yuksel I; Goktas MT; Yasar U; Bozkurt A; Babaoglu MO
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):199-206. PubMed ID: 27611887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.
    Yuki H; Honma T; Hata M; Hoshino T
    Bioorg Med Chem; 2012 Jan; 20(2):775-83. PubMed ID: 22197672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
    Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
    Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Homodimer Metabolites of GDC-0994 via Cytochrome P450-Catalyzed Radical Coupling.
    Takahashi RH; Grandner JM; Bobba S; Liu Y; Beroza P; Zhang D; Ma S
    Drug Metab Dispos; 2020 Jun; 48(6):521-527. PubMed ID: 32234735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective hydroxylation by CYP2C19 and oxidation by ADH4 in the in vitro metabolism of tivantinib.
    Nishiya Y; Nakai D; Urasaki Y; Takakusa H; Ohsuki S; Iwano Y; Yasukochi T; Takayama T; Bazyo S; Oza C; Kurihara A; Savage RE; Izumi T
    Xenobiotica; 2016 Nov; 46(11):967-76. PubMed ID: 26899628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico prediction of the site of oxidation by cytochrome P450 3A4 that leads to the formation of the toxic metabolites of pyrrolizidine alkaloids.
    Fashe MM; Juvonen RO; Petsalo A; Vepsäläinen J; Pasanen M; Rahnasto-Rilla M
    Chem Res Toxicol; 2015 Apr; 28(4):702-10. PubMed ID: 25651456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of rocuronium with human liver cytochromes P450.
    Anzenbacherova E; Spicakova A; Jourova L; Ulrichova J; Adamus M; Bachleda P; Anzenbacher P
    J Pharmacol Sci; 2015 Feb; 127(2):190-5. PubMed ID: 25727956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
    Eng H; Obach RS
    Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
    Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
    Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.